The company has enjoyed years of revenue growth, yet its CEO believes it's still "at the very start of things." ...
Metsera falls sharply after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback